| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/08/2004 | WO2004003225A1 Method for high throughput screening of plant growth regulator |
| 01/08/2004 | WO2004003224A1 Electrochemical sensing using an enzyme electrode |
| 01/08/2004 | WO2004003223A2 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 01/08/2004 | WO2004003222A2 Method for screening for kinase inhibitors |
| 01/08/2004 | WO2004003220A2 Methods and composition for analyzing compromised samples using snps |
| 01/08/2004 | WO2004003202A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 01/08/2004 | WO2004003198A1 Method of examining allergic disease and drug for treating the same |
| 01/08/2004 | WO2004003195A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | WO2004003185A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 01/08/2004 | WO2004003179A1 Differentiation modulating agents and uses therefor |
| 01/08/2004 | WO2004003173A2 Method for detecting mutated polynucleotides within a large population of wild-type polynucleotides |
| 01/08/2004 | WO2004003171A2 Analysis and modification of gene expression in marine invertebrate cells |
| 01/08/2004 | WO2004003167A2 Gucy1b2 genetic markers for ldl cholesterol response to statin therapy |
| 01/08/2004 | WO2004003156A2 Il-21 as a regulator of immunoglobin production |
| 01/08/2004 | WO2004003139A2 Modified shine-dalgarno sequences and methods of use thereof |
| 01/08/2004 | WO2004003136A2 Methods of detecting sequence differences |
| 01/08/2004 | WO2004003132A2 Methods and systems of biomolecular sequence matching |
| 01/08/2004 | WO2004003003A1 Methods for identifying cancer risk |
| 01/08/2004 | WO2004002995A1 Phosphoramidites for coupling oligonucleotides to [2 + 2] photoreactive groups |
| 01/08/2004 | WO2004002976A1 Disruption of pqs synthesis using precursor analogs |
| 01/08/2004 | WO2004002515A1 Diagnostics/preventives/remedies for respiratory diseases |
| 01/08/2004 | WO2004002470A1 Compounds useful for the inhibition of aldh |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002296A2 Therapeutic methods for reducing fat deposition and treating associated conditions |
| 01/08/2004 | WO2004002295A2 Diagnosing predisposition to fat deposition and associated condition |
| 01/08/2004 | WO2004002294A2 Plasma or serum marker and process for detection of cancer |
| 01/08/2004 | WO2004002223A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/08/2004 | WO2003097857A3 Method for the detection of aquaretic compounds |
| 01/08/2004 | WO2003091408A3 Characterization of single stranded nucleic acids by melting analysis using a double strand specific nucleic acid dye |
| 01/08/2004 | WO2003087397A3 Process control based on microbiological activity |
| 01/08/2004 | WO2003086233A3 Thermal monitoring of tissue perfusion with recalibration. |
| 01/08/2004 | WO2003085090A3 A human ribonucleotide reductase m2 subunit |
| 01/08/2004 | WO2003083137A3 Detection of circularized immobilized nucleic acid probes |
| 01/08/2004 | WO2003083130A3 Detection of malaria parasites by mass spectrometry |
| 01/08/2004 | WO2003083044A3 Tissue analogs for in vitro testing and method of use therefor |
| 01/08/2004 | WO2003078959A3 Methods for shp1 mediated neuroprotection |
| 01/08/2004 | WO2003078625A3 An improved method for synthesising templated molecules |
| 01/08/2004 | WO2003076949A3 Tagging and recovery of elements associated with target molecules |
| 01/08/2004 | WO2003075844A3 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
| 01/08/2004 | WO2003074732A3 Methods based on hormone dependency of primary cancer cells |
| 01/08/2004 | WO2003074731A3 Nucleic acid probes, their synthesis and use |
| 01/08/2004 | WO2003072051A3 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same |
| 01/08/2004 | WO2003070877A3 Nucleic acid amplification |
| 01/08/2004 | WO2003068928A3 Gene function inferring using gene expression data |
| 01/08/2004 | WO2003068918A3 High-sensitivity real-time polymerase chain reaction for detection of nucleic acids |
| 01/08/2004 | WO2003067262A3 Methods and compositions involving the hsp90 activator aha1 |
| 01/08/2004 | WO2003064990A3 Lid element |
| 01/08/2004 | WO2003064699A3 Apparatus for synthesis of arrays of dna probes |
| 01/08/2004 | WO2003063766A3 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/08/2004 | WO2003062459A3 Method for specifically identifying methylglyoxal in liquid and/or gaseous samples |
| 01/08/2004 | WO2003062454A3 Compositions and methods for polynucleotide sequence determination |
| 01/08/2004 | WO2003060478A3 Methods and compositions for assaying homocysteine |
| 01/08/2004 | WO2003060158A3 Apoe genotype as a prognostic marker for hepatitis |
| 01/08/2004 | WO2003057915A3 Methods of detecting hcv genotype 1 (hcv-1) by using primers specific for the 5’ non-coding region (ncr) of the hcv genome |
| 01/08/2004 | WO2003056298A3 Sensitive coded detection systems |
| 01/08/2004 | WO2003054552A3 Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing |
| 01/08/2004 | WO2003050302A3 Tgnp activity or expression as marker for apoptosis |
| 01/08/2004 | WO2003050135A3 Use a parapox b2l protein to modify immune responses to administered antigens |
| 01/08/2004 | WO2003035895A3 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
| 01/08/2004 | WO2003025198A3 Regulatory single nucleotide polymorphisms and methods therefor |
| 01/08/2004 | WO2003022986A3 Identification and quantification of nucleic acids by the production and serial sequencing of sequence tags having a uniform length |
| 01/08/2004 | WO2003018837A3 Method and diagnostic kit for the molecular diagnosis of pharmacologically relevant genes |
| 01/08/2004 | WO2003008533A3 Method for virus propagation |
| 01/08/2004 | WO2003007800A3 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/08/2004 | WO2003003018A3 Method for identifying compounds for the therapy of aging of the cardiovascular system |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002099036A3 Inhibition of neurodegeneration |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002083983A3 Determination of accelerator concentration in phosphating baths |
| 01/08/2004 | WO2002080952A3 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 01/08/2004 | WO2002079496A3 Method and sequences for determinate nucleic acid hybridization |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002066654A3 Drug metabolizing enzymes |
| 01/08/2004 | WO2002064797A3 Mitochondrial topoisomerase i |
| 01/08/2004 | WO2002063035A3 Fluorescent assay for proteolysis |
| 01/08/2004 | WO2002059310A3 Polynucleotides encoding cellular transporters and methods of use thereof |
| 01/08/2004 | WO2002059142A3 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications |
| 01/08/2004 | WO2002053594A3 Inhibitors of memapsin 2 and use thereof |
| 01/08/2004 | WO2002046751A3 Methods of predicting chemotherapy response |
| 01/08/2004 | WO2002046460A3 Method for detecting risk of atherosclerosis |
| 01/08/2004 | WO2002046458A3 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 01/08/2004 | WO2002044426A3 Nod2 nucleic acids and proteins |
| 01/08/2004 | WO2002044398A3 Universal supports for oligonucleotide synthesis |
| 01/08/2004 | WO2002040702A3 Methods for the treatment of cancer and other diseases and methods of developing the same |
| 01/08/2004 | US20040006790 Generating disease resistant cucumbers; biological pest control; fungicides |
| 01/08/2004 | US20040006782 Non-human mammal mutant for expression of the alpha6 subunit of the nicotinic acetylcholine receptor, and use for screening substances that can interact with said receptor |
| 01/08/2004 | US20040006780 VEGF-modulated genes and methods employing them |
| 01/08/2004 | US20040006779 Antibodies against gene products related to werner's syndrome |
| 01/08/2004 | US20040006776 Transgenic production of antibodies in milk |
| 01/08/2004 | US20040006434 Providing library of transposon insertion mutants of organism; isolating chromosomal DNA from; digesting chromosomal DNA with a restriction endonuclease; self-ligating; amplifying; transcribing RNA; hybridising; identifying probe |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040006205 Comprises g-protein coupled receptor polypeptides for diagnosis, prevention and treatment of cancers, infections and dyslipidemias |
| 01/08/2004 | US20040006040 Method for the identification and treatment of pathogenic microorganism infections by inhibiting one or more enzymes in an essential metabolic pathway and compounds and pharmaceutical compositions useful therefor |
| 01/08/2004 | US20040006033 Polynucleotides is prepared by subtractive hybridization between test and reference polynucleotide samples and is enriched in sequences that are either not present in reference polynucleotide sample or are present in lower concentration |
| 01/08/2004 | US20040006016 Isolated nucleic acids molecules, designated 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors and fusion proteins |
| 01/08/2004 | US20040005721 Apparatus comprising oxidoreductase for determining glucose concentration of sample |
| 01/08/2004 | US20040005718 Method of fixing biopolymers to a substrate using magnetic beads and biopolymer measuring equipment using the method |
| 01/08/2004 | US20040005709 Hybridization control of sequence variation |
| 01/08/2004 | US20040005704 Propagating neuronal cells in reduced oxygen environment for treating parkinson's and neurodegenerative diseases; in vitro culture and cell differentiation/proliferation; gene therapy; tissue engineering; antiapoptosis |
| 01/08/2004 | US20040005701 Using trophoblast inducing factor to differentiate primate stem cells into trophoblast; tissue engineering; cell differentiation/proliferation |